Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease.Arthritis Rheum. Aug 2004;50(8):2400-14. [Medline].

Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.JAMA. Aug 17 2011;306(7):711-20. [Medline].

Emmerson BT, Gordon RB, Cross M, et al. Plasma oxipurinol concentrations during allopurinol therapy. Br J Rheumatol. Dec 1987;26(6):445-9. [Medline].

Huang HY, Appel LJ, Choi MJ, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum. Jun 2005;52(6):1843-7. [Medline].

So A, De Smedt T, Revaz S, et al. A pilot study of IL-1 inhibition by anakinra in acute gout.Arthritis Res Ther. 2007;9(2):R28. [Medline].

Lee YH, Lee CH, Lee J. Effect of fenofibrate in combination with urate lowering agents in patients with gout. Korean J Intern Med. Jun 2006;21(2):89-93. [Medline].

Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. Mar 2011;23(2):192-202. [Medline].

Dalbeth N, Horne A, Gamble GD, Ames R, Mason B, McQueen FM, et al. The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial. Rheumatology (Oxford). Feb 2009;48(2):195-7. [Medline].

Schumacher HR Jr, Becker MA, Lloyd E, MacDonald PA, Lademacher C. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

1  . . .15 16 17 18 19 20 21 22